Glioblastoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Tie2-FGFR1 Interaction Induces Adaptive PI3K Inhibitor Resistance by Upregulating Aurora A/PLK1/CDK1 Signaling in Glioblastoma.
|
31416846 |
2019 |
Glioblastoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
These findings reveal a new signaling axis for GSC maintenance and highlight ADAMDEC1 and FGFR1 as potential therapeutic targets in GBM.
|
31434712 |
2019 |
Glioblastoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Alpha6-Integrin Regulates FGFR1 Expression through the ZEB1/YAP1 Transcription Complex in Glioblastoma Stem Cells Resulting in Enhanced Proliferation and Stemness.
|
30909436 |
2019 |
Glioblastoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Silencing FGFR1 or FOXM1 downregulated genes involved in mesenchymal transition such as GLI2, TWIST1, and ZEB1 in glioblastoma stem-like cells.
|
30167084 |
2018 |
Glioblastoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Taken together, our results offer a preclinical proof of concept that FGFR1 targeting can degrade radioresistance in glioblastoma, a widespread problem in this tumor, prompting clinical investigations of the use of FGFR1 inhibitors for radiosensitization.
|
26896280 |
2016 |
Glioblastoma
|
0.200 |
GeneticVariation
|
disease |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
Glioblastoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
FGFR1 and FGFR3 genes are fused to neighboring TACC1 and TACC3 genes, respectively, due to interstitial deletions in glioblastoma multiforme.
|
23696246 |
2014 |
Glioblastoma
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Down-regulation of FGFR1 and, consequently, inactivation of its signaling pathways represent novel treatment strategies for glioblastoma.
|
22903848 |
2013 |
Glioblastoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Blockade of FGFR1-mediated signals by pharmacological FGFR inhibitors or a dominant-negative FGFR1 IIIc protein inhibited GBM cell proliferation and/or induced apoptotic cell death.
|
18362893 |
2008 |
Glioblastoma
|
0.200 |
Biomarker
|
disease |
LHGDN |
EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line.
|
18790757 |
2008 |
Glioblastoma
|
0.200 |
GeneticVariation
|
disease |
LHGDN |
Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas.
|
16186508 |
2005 |
Glioblastoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The correction of FGFR1 gene splicing to >90% alpha-exon inclusion in glioblastoma cells had no discernable effect on cell growth in culture, but was associated with an increase in unstimulated caspase-3 and -7 activity.
|
15333583 |
2004 |
Glioblastoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors.
|
10728679 |
2000 |
Glioblastoma
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Glioblastoma (the most malignant form of astrocytoma) cell lines, which exhibit the same pattern of FGFR gene expression as glioblastoma biopsies, were used to evaluate the contribution of FGFR1 expression to glioblastoma cell growth.
|
10498824 |
1999 |
Glioblastoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Redundant intronic repressors function to inhibit fibroblast growth factor receptor-1 alpha-exon recognition in glioblastoma cells.
|
10488155 |
1999 |
Glioblastoma
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Glioblastomas also expressed an alternatively spliced form of FGFR1 containing two immunoglobulin-like disulfide loops (FGFR1 beta), whereas normal human adult and fetal brain expressed a form of the receptor containing three immunoglobulin-like disulfide loops (FGFR1 alpha).
|
7964981 |
1994 |
Glioblastoma
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Examination of the FGFR1 gene by Southern blot analysis indicated that overexpression of FGFR1 mRNA in glioblastomas did not result from gene amplification.
|
8168112 |
1994 |